Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Femoral nerve block versus intravenous ketamine for pain control during positioning before spinal anesthesia in elderly patients with femur fracture
PACTR202112605652525Phase 4Completed
- Sponsor
- Ain Shams University Faculty of Medicine
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ketamine and ropivacaine in femoral fracture and acute pain (2 arms), sponsored by Ain Shams University Faculty of Medicine. Primary endpoint: Pain response before positioning for spinal anesthesia. Started Jan 2020; status: completed.
02
Drugs
ketamineropivacaine
03
Conditions
femoral fractureacute pain
Beyond the preview
Go deeper on PACTR202112605652525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202112605652525.